Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
36.46
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
36.46
-0.01 (-0.01%)
After-hours: Nov 13, 2026, 7:30 PM EST
Pacira BioSciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 37.73 | 7.03 | -99.56 | 41.96 | 15.91 | 41.98 |
Depreciation & Amortization | 88.65 | 91.02 | 78.79 | 75.57 | 81 | 28.55 |
Other Amortization | 3 | 3 | 3.22 | 3.75 | 7.21 | 25.91 |
Loss (Gain) From Sale of Assets | -6.62 | - | - | - | - | - |
Asset Writedown & Restructuring Costs | -5.5 | 25.87 | 163.24 | - | 36.63 | - |
Loss (Gain) From Sale of Investments | -1.99 | 6.07 | -7.42 | -4.58 | 10 | - |
Stock-Based Compensation | 53.82 | 57.5 | 51.17 | 47.9 | 48.09 | 42.25 |
Other Operating Activities | -19.66 | -0.24 | 11.05 | 31.25 | -37.14 | 12.55 |
Change in Accounts Receivable | -11.12 | -10.74 | -7.75 | -7.16 | -2.08 | -10.43 |
Change in Inventory | 18.16 | -27.57 | -20.93 | -8.29 | 2.49 | -4.47 |
Change in Accounts Payable | -2.23 | -5.6 | 3.08 | 0.92 | 6.27 | -10.26 |
Change in Other Net Operating Assets | 22.66 | 5.64 | 14.5 | -26.67 | -23.11 | -0.35 |
Operating Cash Flow | 176.9 | 151.99 | 189.39 | 154.65 | 145.27 | 125.72 |
Operating Cash Flow Growth | 25.07% | -19.74% | 22.46% | 6.45% | 15.56% | 63.20% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -7.9 | -15.33 | -10.64 | -15.16 | -30.08 | -45.87 |
Cash Acquisitions | -6.34 | -16.7 | - | - | -32 | -424.04 |
Investment in Securities | 52.02 | 131.52 | -72.64 | 92.7 | -163.11 | 449.12 |
Investing Cash Flow | 111.35 | 99.48 | -83.28 | 77.54 | -225.19 | -20.79 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 101 | 287.5 | 149.55 | - | 363.75 |
Long-Term Debt Repaid | - | -317.8 | -210.89 | -330.31 | -427.69 | - |
Net Debt Issued (Repaid) | -85 | -216.8 | 76.62 | -180.76 | -427.69 | 363.75 |
Issuance of Common Stock | 4.28 | 3.3 | 2.3 | 4.75 | 27.34 | 26.66 |
Repurchase of Common Stock | -107.77 | -153.95 | -25.49 | -0.11 | - | - |
Other Financing Activities | 0.02 | -2.19 | -36.06 | -6.91 | -1.18 | -9.71 |
Financing Cash Flow | -188.47 | -369.63 | 17.36 | -183.03 | -401.53 | 380.69 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.41 | -0.08 | - | - | - | - |
Net Cash Flow | 99.37 | -118.23 | 123.48 | 49.16 | -481.44 | 485.62 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 169 | 136.66 | 178.75 | 139.49 | 115.2 | 79.85 |
Free Cash Flow Growth | 36.06% | -23.55% | 28.15% | 21.09% | 44.27% | 103.54% |
Free Cash Flow Margin | 22.74% | 18.81% | 25.50% | 20.67% | 17.28% | 14.74% |
Free Cash Flow Per Share | 4.06 | 3.03 | 3.87 | 2.68 | 2.48 | 1.75 |
Levered Free Cash Flow | 187.77 | 108.56 | 163.38 | 107.15 | 92 | 49.79 |
Unlevered Free Cash Flow | 193.59 | 116.47 | 170.52 | 116.09 | 109.78 | 43.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 11.86 | 15.24 | 15.42 | 27.64 | 33.3 | 7 |
Cash Income Tax Paid | 1.28 | 9.01 | 11 | 4.4 | 7.4 | 3.22 |
Change in Working Capital | 27.46 | -38.27 | -11.1 | -41.2 | -16.43 | -25.51 |